American National Bank of Texas’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$578K Hold
2,211
– – 0.53% 29
2026
Q2
$556K Sell
2,211
-600
-21% -$129K 0.51% 27
2026
Q1
$611K Hold
2,811
– – 0.58% 28
2025
Q4
$642K Buy
2,811
+56
+2% +$12.8K 0.62% 27
2025
Q3
$638K Buy
+2,755
New +$561K 0.6% 32

Other funds holding ABBV

American National Bank of Texas's ABBV Position: Q3 2026 in Review

American National Bank of Texas held its AbbVie (ABBV) position steady in Q3 2026 at 2,211 shares worth $578K. The position accounts for 0.53% of the portfolio, ranked #29.

American National Bank of Texas first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. The position peaked at $642K in Q4 2025. 165 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • American National Bank of Texas held 2,211 shares of AbbVie worth $578K as of Q3 2026.
  • American National Bank of Texas left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.53% of American National Bank of Texas's portfolio in Q3 2026, its #29 holding.
  • American National Bank of Texas first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • American National Bank of Texas's AbbVie position peaked at $642K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on American National Bank of Texas's 13F filing for Q3 2026, filed 7 Oct 2026.